MULROY DENNIS (Chief Financial Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2020ACC: 0000920465-20-000083
Officer· Chief Financial Officer
Since Oct 2018
+164.00
Net shares
Net buyer
$328.82
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
164.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+82.00
Price / share
$4.01
Trade value
$328.82
% of position
1.6%
5/29/2020
4.99K→5.07K
Total
Net shares
+82.00
Net value
$328.82
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2020 | A · Award | +82.00 | $4.01 | $328.82 | 1.6% | 4.99K | 5.07K |
| Total | +82.00 | $328.82 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
82.00 shares
Shares
+82.00
Strike price
4.72
Held after
82.00
Exercisable
—
5/29/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock82.00 shares | 5/29/2020 | A · Award | +82.00 | 4.72 | — | 82.00 |